ACM Research, Inc.
50.55USD
+1.4300 (+2.91%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on ACMR.
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 388.8M | 557.7M | 782.1M | 901.3M | 1.2B | 1.5B |
| Q1 | 42.2M | 74.3M | 152.2M | 172.3M | 231.3M | — |
| Q2 | 104.4M | 144.6M | 202.5M | 215.4M | 292.9M | — |
| Q3 | 133.7M | 168.6M | 204.0M | 269.2M | 310.6M | — |
| Q4 | 108.5M* | 170.3M* | 223.5M* | 244.4M* | 338.3M | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | .590 | 1.16 | 1.53 | 1.37 | 2.14 | 2.94 |
| Q1 | -.100 | .110 | .260 | .300 | .240 | — |
| Q2 | .180 | .410 | .350 | .440 | 1.23 | — |
| Q3 | .320 | .390 | .450 | .520 | .517 | — |
| Q4 | .181* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
Revenue to net income
| .273* |
| .469* |
| .120* |
| .537 |
| — |
Debt level and coverage